TOVX
Theriva Biologics·AMEX
--
--(--)
--
--(--)
3.70 / 10
Netural
Fund flow analysis shows a good 7.4/10 score, with Small (0.557) and Large (0.511) blocks indicating positive momentum, despite negative overall and Medium trends. Analyst coverage is limited to one neutral opinion from Maxim Group, contributing to a neutral sentiment. The combination of robust fund inflows and scarce analyst support keeps the overall view neutral, highlighting the need for more analyst participation to validate the current capital movement.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-08
InstitutionMaxim Group
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for TOVX?
- TOVX holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.70/10 (Netural).
